HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of 99mTc-Cysteine in experimental inflammatory lesions in comparison to 99mTc-glutamine and 99mTc-HIG.

AbstractAIM:
The aim of this experimental work was to investigate the efficacy of 99mTc-L-Cysteine (Cys) in scintigraphic visualization of inflammatory lesions in comparison to 99mTc-L-glutamine (G), and 99mTc-HIG.
METHODS:
In mice abscesses were induced by intramuscular injection of turpentine. Six days later mice were injected with 3.7 MBq of each agent and sacrificed in groups of three at 1, 3, 6 and 24 h. Scintigrams were obtained with a gamma camera. The organs, some blood, abscesses, some muscle and urine were removed, weighed and counted in a gamma counter. Percentage of uptake by organs and per gram tissues and abscess/normal tissue concentration ratios were calculated. Experimental arthritis was produced in 6 New Zealand rabbits by intraarticular injection of ovalbumin. Four days later 37 MBq of 99mTc-Cys and 99mTc-HIG were each i.v. administered to 3 rabbits. Scintigrams obtained at 1, 3, 6, and 24 h demonstrated the arthritic joints very well. ROI's over arthritic joints were compared to contralateral normal joints (A/C).
RESULTS:
In mice the abscesses were well visualized on all scintigrams. The maximum abscess/muscle ratios were 5.21 +/- 1.09 (6 h), 3.73 +/- 0.81 (3 h) and 5.98 +/- 1.17 (24 h) and the maximum abscess/blood ratios were 3.46 +/- 1.33 (24 h), 1.81 +/- 0.10 (6 h) and 0.914 +/- 0.351 (24 h) for 99mTc-Cys, 99mTc-G, and 99mTc-HIG, respectively. In rabbits the maximum A/C ratios were 2.61 +/- 0.53 (3 h) and 2.92 +/- 0.99 (24 h) for 99mTc-Cys and 99mTc-HIG, respectively.
CONCLUSION:
Our results indicate that 99mTc-Cys is a promising agent for imaging inflammatory lesions. It is preferred to 99mTc-HIG, because of higher concentration ratios attained earlier, lower blood background, lower cost and a simpler in-house preparation method.
AuthorsM T Ercan, N C Gülaldi, U Uysal, S Unsal, M Aydin, I Peksoy, Z Hasçelik
JournalNuklearmedizin. Nuclear medicine (Nuklearmedizin) Vol. 36 Issue 8 Pg. 265-9 (Dec 1997) ISSN: 0029-5566 [Print] Germany
PMID17068876 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Immunoglobulins
  • Organotechnetium Compounds
  • technetium 99m cysteine
  • technetium 99m glutamine
  • technetium Tc 99m immunoglobulin
  • Glutamine
  • Technetium
  • Cysteine
Topics
  • Animals
  • Arthritis, Experimental (diagnostic imaging)
  • Cysteine (analogs & derivatives, pharmacokinetics)
  • Disease Models, Animal
  • Glutamine (analogs & derivatives, pharmacokinetics)
  • Immunoglobulins
  • Inflammation (diagnostic imaging)
  • Knee Joint (diagnostic imaging)
  • Mice
  • Organotechnetium Compounds (pharmacokinetics)
  • Radionuclide Imaging
  • Technetium (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: